Largest companies by total assets
total assets
| Company | Total assets | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 201 | $93.43M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 202 | $87.73M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 203 | $87.59M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 204 | $82.07M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 205 | $81.68M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 206 | $81.46M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 207 | $80.50M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 208 | $76.87M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 209 | $76.31M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 210 | $73.74M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 211 | $72.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 212 | $72.03M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 213 | $65.97M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 214 | $64.76M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 215 | $62.11M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 216 | $60.84M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 217 | $58.67M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 218 | $56.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 219 | $56.53M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 220 | $54.92M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 221 | $53.63M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 222 | $52.77M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 223 | $51.71M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 224 | $50.07M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 225 | $49.39M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 226 | $47.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 227 | $47.31M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 228 | $46.13M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 229 | $44.71M | Healthcare | Pharmaceuticals | United States | NYSE |
| 230 | $43.47M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 231 | $42.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 232 | $42.29M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 233 | $40.43M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 234 | $40.34M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 235 | $37.53M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 236 | $36.64M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 237 | $36.56M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 238 | $36.02M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 239 | $35.74M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 240 | $34.19M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 241 | $34.16M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 242 | $33.63M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 243 | $33.07M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 244 | $32.47M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 245 | $32.28M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 246 | $32.12M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 247 | $31.75M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 248 | $31.33M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 249 | $30.71M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 250 | $29.09M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 251 | $28.71M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 252 | $28.24M | Healthcare | Pharmaceuticals | United States | NYSE |
| 253 | $27.12M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 254 | $26.81M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 255 | $26.77M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 256 | $26.65M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 257 | $26.20M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 258 | $25.81M | Healthcare | Pharmaceuticals | United States | NYSE |
| 259 | $24.16M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 260 | $24.06M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 261 | $23.78M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 262 | $23.04M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 263 | $22.81M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 264 | $22.62M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 265 | $22.37M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 266 | $22.04M | Healthcare | Pharmaceuticals | United States | NYSE |
| 267 | $21.94M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 268 | $21.09M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 269 | $19.50M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 270 | $19.40M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 271 | $18.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 272 | $17.52M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 273 | $17.14M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 274 | $16.96M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 275 | $16.43M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 276 | $15.61M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 277 | $15.49M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 278 | $15.42M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 279 | $15.07M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 280 | $14.99M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 281 | $14.83M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 282 | $14.61M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 283 | $14.59M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 284 | $14.52M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 285 | $14.31M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 286 | $14.25M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 287 | $13.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 288 | $13.27M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 289 | $12.72M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 290 | $12.50M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 291 | $11.99M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 292 | $11.81M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 293 | $11.47M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 294 | $11.40M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 295 | $11.38M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 296 | $11.03M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 297 | $10.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 298 | $10.58M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 299 | $10.50M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 300 | $9.90M | Healthcare | Pharmaceuticals | United States | NYSE |
U.S.-exchange common stocks; ADRs and funds excluded. 342 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.